RASA1 and non-small cell lung carcinoma: Mutations in RASA1 and NF1 co-occur in human non-small cell lung cancer [61], which may reflect independent mechanisms by which RASA1 and NF1 inhibit RAS or the clonal diversity within these tumors that preferentially selects one of these mechanisms.